| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $94.1M | -16.1% |
| Cost of Revenue | $39.4M | -14.7% |
| Gross Profit | $54.8M | -17.1% |
| R&D Expense | $10.4M | -11.5% |
| SG&A Expense | $21.5M | -5.6% |
| Operating Income | -$6.2M | -427.9% |
| Pre-tax Income | -$11.7M | -356.4% |
| Income Tax | $740K | -13.9% |
| Net Income | -$12.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -4.1% |
| Accounts Receivable | $14.9M | -7.7% |
| Inventory | $23.2M | -6.0% |
| Current Assets | $45.1M | -8.0% |
| Total Assets | $126.6M | -7.8% |
| Current Liabilities | $55.0M | +107.1% |
| Long-term Debt | $37.0M | +1.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.4M | -89.7% |
| Capital Expenditures | $2.6M | +47.9% |
| Investing Cash Flow | -$1.3M | +25.3% |
| Financing Cash Flow | -$131K | +98.9% |
| Free Cash Flow | -$1.2M | -109.8% |
| -263.3% |
| EPS (Basic) | -$0.28 | -250.0% |
| EPS (Diluted) | -$0.28 | -250.0% |
| Total Liabilities |
| $63.3M |
| -1.5% |
| Stockholders' Equity | $63.3M | -13.3% |